Myocardial Infarction Drugs: 2025 ACS Guideline, Reperfusion and Secondary Prevention
Updated 10 November 2026. Educational content only; individual clinical care requires current local guidelines and product labeling. Overview Myocardial infarction (MI) is a time-critical manifestation of acute coronary syndrome (ACS). ST-elevation myocardial infarction (STEMI) and non-ST-elevation ACS require rapid ECG assessment, troponin testing and appropriate reperfusion/risk stratification. Pharmacotherapy complements—not replaces—urgent percutaneous coronary intervention (PCI) when…